Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
342.5 GBX | -0.72% | -2.84% | -2.84% |
Mar. 13 | BTIG Adjusts Price Target on MaxCyte to $8 From $10, Maintains Buy Rating | MT |
Mar. 13 | MaxCyte loss widens in 2023 as core revenue declines 25% | AN |
Chart calendar MaxCyte, Inc.
Upcoming events on MaxCyte, Inc.
Past events on MaxCyte, Inc.
2024-03-12 04:30 pm | Q4 2023 Earnings Call |
2024-03-12 04:05 pm | Q4 2023 Earnings Release |
2024-03-05 09:10 am | TD Cowen Health Care Conference |
2024-02-12 | BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
2023-11-16 10:00 am | Stephens Investment Conference |
2023-11-15 09:10 am | Stifel Healthcare Conference |
2023-11-08 04:30 pm | Q3 2023 Earnings Call |
2023-11-08 04:05 pm | Q3 2023 Earnings Release |
2023-10-11 12:00 am | Cell & Gene Meeting on the Mesa Conference |
2023-10-04 04:30 pm | Q3 2023 Guidance Call |
2023-09-13 02:35 pm | Baird Global Healthcare Conference |
2023-08-09 04:30 pm | Q2 2023 Earnings Call |
2023-08-09 04:05 pm | Q2 2023 Earnings Release |
2023-06-26 06:10 pm | TD Cowen Tools/Dx Revolution Conference |
2023-06-22 11:00 am | Annual General Meeting |
2023-06-08 09:00 am | William Blair Growth Stock Conference |
2023-05-10 04:30 pm | Q1 2023 Earnings Call |
2023-05-10 04:05 pm | Q1 2023 Earnings Release |
2023-03-15 08:07 pm | Q4 2022 Earnings Release |
2023-03-15 04:30 pm | Q4 2022 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 21,6 21,4 1.19% | 26,2 26,2 -0.12% | 33,9 33,4 1.39% | 44,3 44,8 -1.24% | 41,3 39,7 4.12% | 34,2 |
EBITDA Million USD | Released Forecast Spread | -11,8 -13,4 12.11% | -10,0 -8,70 -15.05% | -17,4 -9,36 -86.15% | -24,8 -15,5 -59.67% | -44,1 -39,6 -11.48% | -50,8 |
EBIT Million USD | Released Forecast Spread | -12,4 -14,4 13.55% | -11,1 -12,9 14.07% | -18,2 -17,4 -4.79% | -27,4 -23,9 -14.29% | -48,3 -50,0 3.49% | -59,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,9 -14,9 13.16% | -11,8 -12,1 1.94% | -19,1 -19,3 1.13% | -23,6 -24,6 4.18% | -37,9 -39,1 2.93% | -50,0 |
Net income Million USD | Released Forecast Spread | -12,9 -14,9 13.25% | -11,8 -11,9 0.49% | -19,1 -18,8 -1.65% | -23,6 -25,2 6.37% | -37,9 -40,6 6.69% | -51,9 |
EPS USD | Released Forecast Spread | -0,23 -0,25 7.07% | -0,17 -0,19 10.99% | -0,21 -0,22 2.7% | -0,23 -0,25 6.5% | -0,37 -0,38 3.48% | -0,50 |
Announcement Date | 21/04/20 | 20/04/21 | 22/03/22 | 15/03/23 | 12/03/24 | - |
Quarterly results
Fiscal Period | December | 2020 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 10,9 | 10,2 9,62 5.48% | 11,6 8,46 36.97% | 9,61 9,23 4.09% | 10,6 10,4 2.04% | 12,4 13,1 -5.34% | 8,58 8,26 3.77% | 9,04 10,7 -15.15% | 8,00 8,11 -1.3% | 15,7 15,1 4.02% | 7,51 | 8,13 | 8,93 | 9,66 | 10,3 |
EBITDA Million USD | Released Forecast Spread | -4,54 -3,15 -44.21% | -3,67 -5,16 28.83% | -8,19 -6,44 -27.16% | -7,09 -7,03 -0.75% | -5,84 -2,50 -133.68% | -12,2 -10,4 -17.52% | -12,0 -10,4 -15.89% | -12,9 -10,8 -18.9% | -6,99 -7,62 8.2% | -13,1 | -12,8 | -12,5 | -12,4 | -12,3 | |
EBIT Million USD | Released Forecast Spread | -4,96 -4,77 -3.98% | -4,16 -6,70 37.9% | -8,74 -7,81 -11.88% | -7,71 -8,48 9.1% | -6,75 -5,98 -12.97% | -13,2 -11,7 -12.8% | -13,1 -11,5 -13.78% | -14,0 -12,3 -13.51% | -8,10 -9,83 17.61% | -15,6 | -15,2 | -14,5 | -14,3 | -12,3 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,07 -6,90 41.05% | -8,26 -7,50 -10.14% | -6,43 -8,40 23.41% | -4,81 -6,65 27.68% | -10,9 -11,0 0.78% | -10,5 -9,75 -7.81% | -11,3 -9,65 -16.6% | -5,28 -6,39 17.44% | -13,2 | -12,8 | -12,2 | -11,9 | |||
Net income Million USD | Released Forecast Spread | -4,87 -4,78 -1.89% | -4,07 -7,30 44.25% | -8,26 -8,43 2% | -6,43 -9,08 29.16% | -4,81 -6,85 29.79% | -10,9 -11,3 3.96% | -10,5 -10,5 -0.41% | -11,3 -10,2 -10.76% | -5,28 -8,00 34% | -13,7 | -13,3 | -12,6 | -12,3 | -10,5 | |
EPS USD | Released Forecast Spread | -0,10 | -0,05 -0,06 16.67% | -0,04 -0,07 44.44% | -0,08 -0,08 0% | -0,06 -0,09 31.82% | -0,05 -0,08 33.33% | -0,11 -0,11 1.79% | -0,10 -0,10 -4.17% | -0,11 -0,10 -7.84% | -0,05 -0,07 28.57% | -0,13 | -0,12 | -0,12 | -0,12 | -0,10 |
Announcement Date | 21/09/20 | 22/03/22 | 09/05/22 | 10/08/22 | 09/11/22 | 15/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 12/03/24 | - | - | - | - | - |
Past sector events for MaxCyte, Inc.
Today | EDAN INSTRUMENTS, INC.: Q4 2023 Earnings Release |
2024-03-28 01:55 am | STRATEC SE: Q4 2023 Earnings Release |
2024-03-27 | QINGDAO HAIER BIOMEDICAL CO.,LTD: Q4 2023 Earnings Release |
2024-03-27 | LIFETECH SCIENTIFIC CORPORATION: Q4 2023 Earnings Release |
2024-03-27 | MICROPORT SCIENTIFIC CORPORATION: Q4 2023 Earnings Release |
2024-03-26 | SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD.: Q4 2023 Earnings Release |
2024-03-07 01:30 am | DRÄGERWERK AG & CO. KGAA: Q4 2023 Earnings Release |
2024-03-06 02:00 am | OXFORD NANOPORE TECHNOLOGIES PLC: Q4 2023 Earnings Release |
2024-02-29 04:00 pm | QUANTERIX CORPORATION: Q4 2023 Earnings Release |
2024-02-29 01:30 am | ELEKTA AB: Q3 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock MaxCyte, Inc. - London S.E.
- Calendar MaxCyte, Inc.